Trial Profile

Prevention of Sporadic Colorectal Adenomas With Celecoxib

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 20 Mar 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Celecoxib (Primary)
Indications Colorectal cancer; Polyps; Sporadic adenomas
Focus Adverse reactions; Therapeutic Use
Acronyms APC

Most Recent Events

21 Jan 2017 Results of a biomarker analysis presented at the 2017 Gastrointestinal Cancers Symposium.
22 Apr 2013 Endpoints updated (ex VANS).
11 Apr 2013 Planned number of patients changed from 1000 to 1170 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com